Tonix Pharmaceuticals Holding Corp.(NASDAQ : TNXP)
TNXP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Pharmaceuticals Other
|SAVA||Cassava Sciences, Inc.||-2.07%||53.49||0.0%||$435.88m|
|HZNP||Horizon Therapeutics Plc||1.65%||103.76||5.4%||$197.51m|
|VRX||Valeant Pharmaceuticals International, Inc.||-4.49%||23.83||14.1%||$140.22m|
|UTHR||United Therapeutics Corp.||-2.32%||189.50||13.9%||$79.26m|
|JAZZ||Jazz Pharmaceuticals Plc||-2.08%||119.87||2.1%||$71.81m|
|BHC||Bausch Health Cos., Inc.||-4.49%||23.83||0.0%||$71.24m|
|PRGO||Perrigo Co. Plc||-2.05%||36.71||6.9%||$55.85m|
|CPIX||Cumberland Pharmaceuticals, Inc.||128.64%||5.03||0.6%||$53.21m|
|ENDP||Endo International Plc||-4.11%||5.60||8.5%||$51.98m|
|QLGN||Qualigen Therapeutics, Inc.||-6.96%||1.47||0.0%||$27.60m|
|AXSM||Axsome Therapeutics, Inc.||0.58%||34.54||1.8%||$24.89m|
|IRWD||Ironwood Pharmaceuticals, Inc.||2.12%||11.09||9.5%||$24.26m|
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.